AU Patent

AU2006326551B2 — Fexofenadine suspension formulation

Assigned to Chattem Inc · Expires 2012-06-07 · 14y expired

What this patent protects

The present invention is directed to an aqueous pharmaceutical suspension of fexofenadine zwitterionic dihydrate Form I.

USPTO Abstract

The present invention is directed to an aqueous pharmaceutical suspension of fexofenadine zwitterionic dihydrate Form I.

Drugs covered by this patent

fexofenadine-hydrochloride (FEXOFENADINE HYDROCHLORIDE)

Patent Metadata

Patent number: AU2006326551B2
Jurisdiction: AU
Classification: —
Expires: 2012-06-07
Drug substance claim: No
Drug product claim: No
Assignee: Chattem Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.